Respiratory News and Research

RSS

Watch-and-wait approach feasible following adjuvant therapy for rectal cancer

Patients with rectal cancer managed conservatively following a complete response to chemoradiotherapy achieve similar rates of disease control as those who undergo rectal resection, research shows.

21 Nov 2012

Cataract specifics are not relevant to postsurgery improvement

Patient-reported improvements in vision after cataract surgery are high and are unrelated to the level of ocular comorbidity or whether the surgery is in the first or second eye, report researchers.

21 Nov 2012

Exercise relieves cancer fatigue

A review of studies spanning 45 years shows that exercise, particularly aerobic rather than strength- or flexibility-based training, improves fatigue in cancer patients.

21 Nov 2012

WHO DG Chan says media allegations of agency receiving food industry funding to fight NCDs 'wrong'

In a statement released on Monday, WHO Director-General Margaret Chan said "[s]everal recent media articles are creating misinformation and confusion in the public health arena" by "erroneously suggesting that, in working to reduce non-communicable diseases (NCDs) such as cardiovascular diseases, cancers, chronic respiratory diseases and diabetes, WHO receives funding from the food and beverage industry," the U.N. News Centre reports.

21 Nov 2012

Acute cough should raise asthma alarm

Around one-fifth of patients consulting their primary care physician for acute cough could have undiagnosed asthma or chronic obstructive pulmonary disease, show the results of a pan-European study.

20 Nov 2012

Glycoprotein gene flags up heart disease

The glycosylphosphotidylinositol-anchored membrane glycoprotein CD14 gene significantly predicts cardiovascular mortality in adults aged 65 years or over, research shows.

20 Nov 2012

Aradigm’s Lipoquin provides full protection in murine models of pneumonic plague

Scientists from the UK Defence Science and Technology Laboratory (Dstl) report, in a preliminary study, that they have demonstrated that a single dose of Aradigm Corporation's liposomal ciprofloxacin formulation Lipoquin administered 24 hours after exposure to a lethal dose of the bacterium Yersinia pestis provided full protection in a murine model of pneumonic plague.

20 Nov 2012

Diffusion Pharmaceuticals completes trans sodium crocetinate Phase I trial on glioblastoma

Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium crocetinate (TSC) in nine patients with newly diagnosed primary brain cancer (glioblastoma or GBM).

19 Nov 2012

Immunologic diseases linked to poorer survival in PSC

Primary sclerosing cholangitis patients with concomitant immunologic disorders, have reduced transplantation-free survival compared with patients without, say the authors of a German study.

19 Nov 2012

Young relatives of sudden cardiac death individuals at high heart disease risk

Young first- and second-degree relatives of individuals who were victims of sudden cardiac death are at a significantly increased risk for developing cardiovascular disease, research suggests.

19 Nov 2012

Geriatric team improves outcomes in elderly emergency department patients

Collaboration between trauma and geriatric specialists can improve outcomes for elderly patients admitted to the emergency department, indicate Canadian study findings.

19 Nov 2012

Geriatric health, lungs adversely affected by air pollution

Elderly individuals living in highly polluted areas of the USA have higher levels of inflammatory markers in their blood compared with their counterparts who live in less-polluted regions, indicate the results of a study.

19 Nov 2012

Marinomed’s Antiviral polymer awarded Chinese patent

Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, today announced that it has been granted Chinese Patent No. CN101678040, entitled 'Antiviral polymer', by the Chinese patent office.

18 Nov 2012

Walgreens community-based programs help raise more than $1.3M in 2012 for JDRF

Walgreens, the nation's largest drugstore chain, and JDRF, the world's largest charitable funder of research toward curing, treating, and preventing type 1 diabetes (T1D) and its complications, today announced that Walgreens community-based programs helped raise more than $1.3 million in 2012 for JDRF.

17 Nov 2012